200,000+ products from a single source!

sales@angenechem.com

Home > Self-healing PEG-poly(aspartic acid) hydrogel with rapid shape recovery and drug release

Self-healing PEG-poly(aspartic acid) hydrogel with rapid shape recovery and drug release

 

 

Heng Ana, Linmiao Zhub, Jiafu Shena, Wenjuan Li, Yong Wang, Jianglei Qin

1.Introduction
Hydrogels are very appealing biomedical materials in applications of biomedical areas, ranging from drug delivery to tissue engineering with their higher water content and solid-like mechanical properties [1–4]. The hydrogels can be prepared from either physical cross-linking through intermolecular interaction or a covalent bond with each has its advantages and disadvantages [5–8]. In the past decade, the self- healing hydrogels were prepared based on intermolecular interaction [6,9–13] or reversible covalent bonds like acyl hydrazone bond [14–16], oxime bonds [17,18], and boronic ester bond [3,19–23], etc [24–27]. Compared to those hydrogels prepared from carbon chain polymers [10,28,29], the hydrogels prepared from heterochain polymers [14,30] or biodegradable polymers like polysaccharide [16,31], chitosan [26,32], hyaluronic acid [33,34] should have better biocompatibility and bio-safety. It is understandable the hydrogels prepared from poly(aspartic acid) and their derivatives are very fit for bio- applications without worrying about the by-effect [13,32,35–38]. Based on the previous report, the poly(succinimide) (PSI) prepared from aspartic acid can be modified by a variety of amine to form poly(aspartic acid) based hydrogels for biomedical applications [37,39,40]. But the poly (aspartic acid) based self-healing hydrogel has not been studied even if the hydrazide groups, aldehyde groups [35] and catechol units [40] can be easily imported to modified poly(aspartic acid) structures.
In this research, self-healing hydrogel was designed from biodegradable poly(aspartic acid) with hydrazide functional groups and methoxyl groups. The hydrazide group was imported onto the poly(aspartic acid) and partially hydrazide functionalized hydroxyl ethyl grafted poly(aspartic acid) (PAEH) was prepared. Then the PAEH was cross-linked by poly(ethylene glycol) dialdehyde (PEG DA) to prepare self-healing hydrogel with reversible hydrazone bond. The poly(aspartic acid) based hydrogel showed good mechanical property and self- healing property. The easy accessibility of the poly(aspartic acid) based PAEH endows this self-healable hydrogel wide potential application areas. The in vitro biotoxicity investigation revealed that the PAsp based self-healable hydrogel has good bio-compatibility and has great potential bioscience and biotechnology application as drug delivery agent and tissue repairing.


2.Experimental
2.1.Materials
L-Aspartic acid (L-Asp) and 1,3,5-trimethyl benzene were purchased from Macklin Biochemical Co Ltd.  Poly(ethylene glycol)  (PEG45,  Mn = 2k; PEG90, Mn = 4k) were supplied by Guangfu fine chemical research institute and used to prepare PEG DA according to literature [14]. Tetramethylene sulfone was purchased from Sinopharm Chemical Reagent Co. Ltd. Phosphoric acid was supplied by Huadong Reagent Co. Aminoethanol, hydrazine hydrate (80 %), acetone and other solvents including N, N-Dimethylformamide (DMF), Dimethyl sulfoxide (DMSO) and methanol, etc. were supplied by Kermal Chemical Reagent Co. Ltd. and used as received.

 

2.2.Synthesis of ethanolamine grafted poly(aspartic acid) with partially functionalized hydrazide (PAEH)
First, the PSI (Mn = 1.2 × 104) was synthesized by thermal polycondensation reaction of L-Asp catalyzed by H3PO4 according to the previous study [35]. Then the PSI was used to react with hydrazine and ethanolamine successively to prepare PAEH with the following procedures. First, 1.94 g (20 mmol) PSI was dissolved in 10 mL of DMSO in a 50 mL flask, then 0.25 g hydrazine hydrate (80 %, 4 mmol) was added into the flask. The flask was deoxidized and sealed after filled with N2, then the flask was immersed in a 60 °C oil bath for 24 h under continuous stirring. The intermediate was precipitated in methanol and washed three times, then the reaction ratio of the intermediate was characterized by 1H NMR after dried in vacuum oven until constant weight.

 

The intermediate was dissolved in  DMSO  again and  3.05 g  (50 mmol) 2-aminoethanol was added into the flask. The oxygen was removed again and the reaction was performed for another 12 h at 60 °C under N2 protection. The solution was precipitated in acetone and washed twice, the product of PAEH was collected after dried under vacuum (overall yield: 73 %). The composition of the PAEH was characterized by 1H NMR and confirmed by FT-IR.

2.3.Preparation of hydrogels with hydrazone bond linkage
The hydrogels with PAsp backbone and hydrazone bond linkage were prepared in deionized water. First, the PAEH was dissolved in water to form a solution with a 10 % concentration. Then the cross-linkers of PEG DA with various molecular weights were dissolved in deionized water to form a 10 % solution. The two solutions were then mixed together with a 1:1 group ratio of hydrazide to aldehyde. The hydrogel formation at 25 °C was tracked on the rheometer right after the mixing of two solutions. The hydrogels for rheological and self-healing studies were formed directly in a round mold at room temperature without additional stimulus. 

 

2.4.Rheological analysis
The gelation process and mechanical property of hydrogels were determined on a rheometer (TA AR2000ex) at 25 °C. After the hydrogels were formed and incubated for 24 h to the equilibrium state, the mechanical property was characterized with increasing frequency from
0.1 rad s−1 to 100 rad s−1. The storage modulus (G′) and loss modulus (G″) were monitored as a function of frequency. The gelation process was carried out right after mixing of PAEH solution and PEG DA solution, the frequency for this characterization was fixed to 1 rad s−1 and the strain was fixed to 1 %.


2.5.  Self-healing property of PAsp based hydrogels
The hydrazone bond is a dynamic bond that can endow the hydrogels with self-healing property as reported previously [19,30,41]. The hydrogel in this study also exhibited self-healing properties due to the dynamic bonds. The hydrogel plate was cut into 4 pieces and the pieces were put back into the mold with close contact. The healing result was confirmed by suspended to gravity and under stretching.


2.6.Gel-sol-gel transition and degradation of the self-healing hydrogels under various conditions
The reversible characteristics of the dynamic covalent bond endow the hydrogels with multi-triggered transition [29], and the past backbone of the hydrogels endowed the hydrogel with biodegradability [37]. The pH of the hydrogel was regulated to 3.0 by HCl and shaken to see the gel-sol transition, then the sol was neutralized by N(C2H5)3 to observe the sol-gel transition. The gel-sol-gel transition was confirmed by vial leaning and recorded by a digital camera. The past backbone of PAEH is bio-degradable, so the hydrogel was expected to be degradable through the degradation of PAsp. Previous research indicated the PAsp can be degraded slowly under neutral conditions, while mild acid or base can accelerate the degradation rate. In this research, the mild base of NaHCO3 and Na2CO3 was used to degrade the self-healable hydrogel.

0.1 g 10 % NaHCO3 and Na2CO3 solutions were added onto the PAsp based hydrogel (1 g) in a glass vial and sealed to observe the degradation process. Since the volume of the hydrogel kept intact, the gel- sol transition of the hydrogels indicated the degradation of hydrogel through cleavage of the PAsp backbone. The gel-sol transition was confirmed by vial leaning and recorded by a digital camera.

 

2.7.Microstructure of PAsp based hydrogel
The hydrogels were prepared with different cross-linkers of PEG45 DA and PEG90 DA. For the preparation of samples, the hydrogels were lyophilized and broken in liquid nitrogen. The cross-sectional morphology of the hydrogels was observed under a JSM-7500 SEM apparatus after coated with Au.

 

2.8.Thermal stability analysis of the PAsp based hydrogel
The thermal stability of PAEH polymer, PEG DA cross-linker and hydrogel was determined by TGA analysis. The PAEH polymer, PEG45 DA cross-linker, and freeze-dried hydrogel were put in the crucible and subjected to the TGA analysis. The temperature was increased from  25 °C to 800 °C with a heating rate of 20 °C min−1 under the N2 protection. The stability was compared according to the TGA curves.

 

2.9.In vitro release of PAsp based hydrogel loaded DOX·HCl
The in vitro release of drugs from the hydrogels was investigated with different cross-linkers. First, 3 mg of DOX·HCl was dissolved in PEG DA solution, then 10 % PEAH was added to form a 1 g hydrogel plate and incubated for 12 h. Then the hydrogel was placed into a dialysis bag, and immersed in 200 mL pH 7.4 PBS solution. At predetermined intervals, 2 mL PBS was pipette to measure the absorbance of the solutions at 485 nm, and 2 ml fresh PBS solution was added. 


2.10.In vitro cytotoxicity tests of the hydrogels
The cytotoxicity was evaluated by determining the viability of cells exposed to the diluted hydrogel solution using a quantitative 3-(4,5- dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay [30]. The hydrogel solutions were subjected to the evaluation. JB6 P+ cell and HeLa cells were seeded into a 96-well microculture plate at a density of 1 × 104 cells per well and incubated for 24 h at  37 °C in a 5 % CO2 humidified incubator to obtain a confluent monolayer of cells. Thereafter, hydrogel solutions were pipetted into the wells. Experiments were repeated for three times and at least six samples were included in each experiment. After 24 h, the hydrogel solutions were removed following the manufacturer’s instruction. The absorbance of each well was measured at a wavelength of 490 nm using a microplate reader (Bio-Tek, Synergy H1, USA). H2O was loaded as a negative control and 1 % Triton X-100 as a positive control. The samples with a relative cell viability of less than 70 % are deemed to be cytotoxic.

 

2.11.Characterizations
The structure and the composition of the polymers were determined by 1H NMR characterization, which were carried out on a  Bruker  600 MHz spectrometer (Avance III, Bruker) with DMSO-D6 as solvent. The FT-IR spectra of the polymers were obtained on a Varian 600 Fourier-transform infrared (FT-IR) spectrometer. Rheological properties of the hydrogels were measured on a TA AR2000ex rheometer with oscillatory mode at 25 °C between a pair of 25 mm parallel aluminum plates. The morphology of the hydrogels was observed on a field- emission scanning electron microscope (FE-SEM, JSM-7500), the operating voltage of the SEM was 10 kV and the images were recorded by a CCD camera. The hydrogels were freeze-dried and broke in liquid nitrogen to preserve the original morphology. The samples were mounted on an aluminum specimen mounts and coated with Au for observations.

Over 100,000 products now available from Angene:

CAS No. 114239-31-5

1,4-Benzenediol, 2-chloro-5-(1,1-dimethylethyl)-, 1,4-diacetate

Catalog No.:AG000AX0 MDL No.:

MF:C14H17ClO4 MW:284.7354

CAS No. 114239-59-7

Benzaldehyde, 4-ethenyl-, oxime

Catalog No.:AG000AWZ MDL No.:

MF:C9H9NO MW:147.1739

CAS No. 114244-01-8

1-Pyrenehexanoic acid, 1-[[[hydroxy[2-[(2,4,6-trinitrophenyl)amino]ethoxy]phosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester, (R)- (9CI)

Catalog No.:AG000AWY MDL No.:

MF:C49H63N4O14P MW:963.0167

CAS No. 114244-83-6

1H-Pyrrolo[3,2-c]pyridine, 4,6-dichloro-1-methyl-

Catalog No.:AG000AWX MDL No.:

MF:C8H6Cl2N2 MW:201.0526

CAS No. 114245-12-4

Stannane, tributyl[1-methyl-3-(phenylthio)-1,2-propadien-1-yl]-

Catalog No.:AG000AWW MDL No.:

MF:C22H36SSn MW:451.2872

CAS No. 114245-35-1

1H-Stannepin, 1,1-dibutyl-

Catalog No.:AG000AWV MDL No.:

MF:C14H24Sn MW:311.0414

CAS No. 114245-55-5

Benzene, 1-chloro-4-[[(trimethylsilyl)methyl]sulfinyl]-

Catalog No.:AG000AWU MDL No.:

MF:C10H15ClOSSi MW:246.8290

CAS No. 114245-61-3

4-Hepten-3-one, 2,2-dimethyl-6-phenyl-, (4E)-

Catalog No.:AG000AWT MDL No.:

MF:C15H20O MW:216.3187

CAS No. 114245-62-4

2-Penten-1-one, 1,4-diphenyl-, (2E)-

Catalog No.:AG000AWS MDL No.:

MF:C17H16O MW:236.3083

CAS No. 114246-07-0

1-Butene, 2-isothiocyanato-3-methyl-

Catalog No.:AG000AWR MDL No.:

MF:C6H9NS MW:127.2074

CAS No. 114246-51-4

Benzenamine, 4-(4-phenoxy-2-quinazolinyl)-N,N-dipropyl-

Catalog No.:AG000AWQ MDL No.:

MF:C26H27N3O MW:397.5121

CAS No. 114246-72-9

1-Propanesulfonic acid, 3-[(4-iodophenyl)amino]-

Catalog No.:AG000AWP MDL No.:

MF:C9H12INO3S MW:341.1660

CAS No. 114246-76-3

5H-Benzo[a]phenoxazin-5-one, 10-(2-aminoethyl)-

Catalog No.:AG000AWO MDL No.:

MF:C18H14N2O2 MW:290.3160

CAS No. 114246-77-4

5H-Benzo[a]phenoxazin-5-one, 10-(2-aminoethyl)-, nitrate (1:1)

Catalog No.:AG000AWN MDL No.:

MF:C18H15N3O5 MW:353.3288

CAS No. 114251-13-7

6,8-Nonadien-1-ol, (6E)-

Catalog No.:AG000AXP MDL No.:

MF:C9H16O MW:140.2227

CAS No. 114251-99-9

1-Cyclobuten-3-yne

Catalog No.:AG000AXO MDL No.:

MF:C4H2 MW:50.0587

CAS No. 114253-18-8

1H-Indol-3-ol, 5-bromo-

Catalog No.:AG000AXN MDL No.:

MF:C8H6BrNO MW:212.0433

CAS No. 114254-48-7

1,4-Benzenediamine, N1,N1-bis(4-aminophenyl)-, hydrochloride (1:3)

Catalog No.:AG000AXM MDL No.:MFCD22125332

MF:C18H21Cl3N4 MW:399.7451

CAS No. 114255-23-1

tert-Hexane, bromo- (9CI)

Catalog No.:AG000AXL MDL No.:

MF:C6H13Br MW:165.0714

CAS No. 114258-34-3

Alanine, N-[(acetylthio)acetyl]-3-[[(acetylthio)acetyl]amino]- (9CI)

Catalog No.:AG000AXK MDL No.:

MF:C11H16N2O6S2 MW:336.3845

CAS No. 114259-16-4

1(3H)-Isobenzofuranone, 3-(diethylamino)-

Catalog No.:AG000AXJ MDL No.:

MF:C12H15NO2 MW:205.2530

CAS No. 114259-65-3

1-Naphthalenebutanethiol

Catalog No.:AG000AXI MDL No.:

MF:C14H16S MW:216.3418

CAS No. 114259-73-3

Benzoic acid, 5-[(7-chloro-4-quinolinyl)amino]-2-hydroxy-

Catalog No.:AG000AXH MDL No.:

MF:C16H11ClN2O3 MW:314.7231

CAS No. 114259-74-4

Phenol, 4-[(7-chloro-4-quinolinyl)amino]-2-nitro-

Catalog No.:AG000AXG MDL No.:

MF:C15H10ClN3O3 MW:315.7112

CAS No. 114259-86-8

Benzamide, 5-amino-N-ethyl-2-hydroxy-

Catalog No.:AG000AXF MDL No.:

MF:C9H12N2O2 MW:180.2038

CAS No. 114260-11-6

Benzenecarbodithioic acid, 2-fluoro-, methyl ester

Catalog No.:AG000AXE MDL No.:

MF:C8H7FS2 MW:186.2696

CAS No. 114260-14-9

1H-Imidazole-2-carbodithioic acid, 1-methyl-, methyl ester

Catalog No.:AG000AXD MDL No.:

MF:C6H8N2S2 MW:172.2711

CAS No. 114260-17-2

Quinoline, 1,2,3,4-tetrahydro-2-(2-methylpropyl)-

Catalog No.:AG000AXC MDL No.:

MF:C13H19N MW:189.2967

CAS No. 114260-37-6

L-Cysteine, N-acetyl-S-[(6-chloro-2-pyridinyl)methyl]-

Catalog No.:AG000AXB MDL No.:

MF:C11H13ClN2O3S MW:288.7505

CAS No. 114260-43-4

2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-[1,1'-biphenyl]-4-yl-

Catalog No.:AG000AXA MDL No.:

MF:C18H21NO3Si MW:327.4497

CAS No. 114260-51-4

Benzamide, 2-hydroxy-N-(2-hydroxy-5-methylphenyl)-

Catalog No.:AG000AX9 MDL No.:

MF:C14H13NO3 MW:243.2579

CAS No. 114260-59-2

10(7H)-Acephenanthrylenone, 4,5,8,9-tetrahydro-

Catalog No.:AG000AX8 MDL No.:

MF:C16H14O MW:222.2818

CAS No. 114260-95-6

Pyridinium, 3-(aminocarbonyl)-2-methyl-1-(phenylmethyl)-

Catalog No.:AG000AX7 MDL No.:

MF:C14H15N2O+ MW:227.2817

CAS No. 114261-00-6

Pyridinium, 3-(aminocarbonyl)-1,6-dimethyl-

Catalog No.:AG000AX6 MDL No.:

MF:C8H11N2O+ MW:151.1857

CAS No. 114261-04-0

3-Pyridinecarboxamide, 1,4-dihydro-5-methyl-1-(phenylmethyl)-

Catalog No.:AG000AX5 MDL No.:

MF:C14H16N2O MW:228.2896

CAS No. 114261-07-3

1-Propanamine, 3-methoxy-2,2-bis(methoxymethyl)-

Catalog No.:AG000AX4 MDL No.:

MF:C8H19NO3 MW:177.2414

CAS No. 114261-74-4

2-Propen-1-one, 3-(dimethylamino)-1-oxiranyl-, (2E)- (9CI)

Catalog No.:AG000AX3 MDL No.:

MF:C7H11NO2 MW:141.1677

CAS No. 114261-79-9

2-Propen-1-one, 3-(dimethylamino)-1-(3-phenyl-2-oxiranyl)-

Catalog No.:AG000AX2 MDL No.:

MF:C13H15NO2 MW:217.2637

CAS No. 114262-23-6

Thymidine, 3-(4-methoxybenzoyl)-5'-O-(triphenylmethyl)- (9CI)

Catalog No.:AG000AX1 MDL No.:

MF:C37H34N2O7 MW:618.6751

CAS No. 114262-65-6

Benzenamine, 4-(1,1,2,2,3,3,4,4,4-nonafluorobutyl)-

Catalog No.:AG000AYE MDL No.:

MF:C10H6F9N MW:311.1470

CAS No. 114262-78-1

1,4-Naphthalenedicarbonitrile, 5,8-dihydro-

Catalog No.:AG000AYD MDL No.:

MF:C12H8N2 MW:180.2053

CAS No. 114262-85-0

Benzene, 1,1'-[(3-phenylpropylidene)bis(oxymethylene)]bis-

Catalog No.:AG000AYC MDL No.:

MF:C23H24O2 MW:332.4355

CAS No. 114262-88-3

Benzene, (3-methoxy-4-decyn-1-yl)-

Catalog No.:AG000AYB MDL No.:

MF:C17H24O MW:244.3719

CAS No. 114263-23-9

Diazene, 1,1'-(1-cyclohexene-1,2-diyl)bis[2-(4-bromophenyl)-

Catalog No.:AG000AYA MDL No.:

MF:C18H16Br2N4 MW:448.1544

CAS No. 114263-69-3

Selenocyanic acid, 9H-fluoren-9-yl ester

Catalog No.:AG000AY9 MDL No.:

MF:C14H9NSe MW:270.1880

CAS No. 114263-85-3

Spiro[9H-fluorene-9,5'-[1,4,2]oxaselenazole], 3'-(2,4,6-trimethylphenyl)-

Catalog No.:AG000AY8 MDL No.:

MF:C23H19NOSe MW:404.3631

CAS No. 114263-91-1

1H-1,2,3-Triazole, 1-hydroxy-4,5-diphenyl-

Catalog No.:AG000AY7 MDL No.:

MF:C14H11N3O MW:237.2566

CAS No. 114263-97-7

Naphthalene, 1,2,3,4-tetrachloro-1-(1-chloroethyl)-1,2,3,4-tetrahydro-

Catalog No.:AG000AY6 MDL No.:

MF:C12H11Cl5 MW:332.4807

CAS No. 114264-01-6

Tetradecanoic acid, 3-(phenylmethoxy)-, methyl ester, (3R)-

Catalog No.:AG000AY5 MDL No.:

MF:C22H36O3 MW:348.5194

CAS No. 114266-49-8

2,4,10,12-Tetraoxadispiro[5.1.5.3]hexadecan-7-one, 3,11-diethenyl-

Catalog No.:AG000AY4 MDL No.:

MF:C16H22O5 MW:294.3429

CAS No. 114266-71-6

Phosphine oxide, bis(methylphenyl)(2,4,6-trimethylbenzoyl)- (9CI)

Catalog No.:AG000AY3 MDL No.:

MF:C24H25O2P MW:376.4279

CAS No. 114266-78-3

Benzene, methyl(1-methyl-1-phenylethyl)- (9CI)

Catalog No.:AG000AY2 MDL No.:

MF:C16H18 MW:210.3141

CAS No. 114267-97-9

Zinc, (1-methyl-1H-imidazole-N3)[2,3,7,8,12,13,17,18-octaethyl-21H,23H-porphinato(2-)-N21,N22,N23,N24]-, (SP-5-12)- (9CI)

Catalog No.:AG000AY1 MDL No.:

MF:C40H52N6Zn MW:682.2611

CAS No. 114268-45-0

Pyrylium, 2,4,6-tris[3,4-bis(dodecyloxy)phenyl]-

Catalog No.:AG000AY0 MDL No.:

MF:C95H161O7+ MW:1415.2906

CAS No. 114269-32-8

Manganese(3+), bis(2,2'-bipyridine-κN1,κN1')-

Catalog No.:AG000AXZ MDL No.:

MF: MW:

CAS No. 114272-37-6

Pyrrolidine, 1-(2,3-dihydro-1H-inden-5-yl)-

Catalog No.:AG000AXY MDL No.:

MF:C13H17N MW:187.2808

CAS No. 114272-39-8

Ethanone, diphenylselenoxo- (9CI)

Catalog No.:AG000AXX MDL No.:

MF:C14H10OSe MW:273.1886

CAS No. 114273-40-4

Isoquinoline, 4-(2-furanylmethyl)-

Catalog No.:AG000AXW MDL No.:

MF:C14H11NO MW:209.2432

CAS No. 114273-70-0

Propanoic acid, 2,2-dimethyl-, 5-hydroxy-4,4-dimethylpentyl ester

Catalog No.:AG000AXV MDL No.:

MF:C12H24O3 MW:216.3172

CAS No. 114274-09-8

4H-1,2,4-Triazol-4-amine, N-cyclohexyl-

Catalog No.:AG000AXU MDL No.:

MF:C8H14N4 MW:166.2236

CAS No. 114274-16-7

Benzenamine, 2-ethyl-3-methoxy-

Catalog No.:AG000AXT MDL No.:

MF:C9H13NO MW:151.2056

CAS No. 114274-33-8

Pentanoic acid, 5-(dihydro-2(3H)-furanylidene)-, (E)- (9CI)

Catalog No.:AG000AXS MDL No.:

MF:C9H14O3 MW:170.2057

CAS No. 114274-39-4

1,3-Benzenedicarboxylic acid, 5-(phenylmethoxy)-

Catalog No.:AG000AXR MDL No.:

MF:C15H12O5 MW:272.2528

CAS No. 114274-71-4

2-Propenoyl chloride, 3-methoxy-2-methyl-, (2E)-

Catalog No.:AG000AXQ MDL No.:

MF:C5H7ClO2 MW:134.5609

CAS No. 1142811-12-8

Palladium, [2-[2-(amino-κN)ethyl]phenyl-κC][bis(1,1-dimethylethyl)[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine]chloro-

Catalog No.:AG000AYF MDL No.:

MF:C39H61ClNPPd MW:716.7551

CAS No. 114282-45-0

4(3H)-Pyrimidinone, 2-amino-5-hydroxy-6-(hydroxymethyl)-

Catalog No.:AG000AYW MDL No.:

MF:C5H7N3O3 MW:157.1274

CAS No. 114282-64-3

5H-Indeno[2,1-b]quinoline, 5-methyl-11-phenyl-

Catalog No.:AG000AYV MDL No.:

MF:C23H17N MW:307.3878

CAS No. 114282-82-5

Pentanoic acid, 2-hydroxy-3-oxo-

Catalog No.:AG000AYU MDL No.:

MF:C5H8O4 MW:132.1146

CAS No. 114282-83-6

4H-1,3,5-Dithiazine, dihydro-5-nitroso-

Catalog No.:AG000AYT MDL No.:

MF:C3H6N2OS2 MW:150.2225

CAS No. 114283-32-8

5H-[1]Benzopyrano[4,3-b]pyridine-3-carbonitrile, 2-methoxy-4-phenyl-

Catalog No.:AG000AYS MDL No.:

MF:C20H14N2O2 MW:314.3374

CAS No. 114284-26-3

Pyridine, 1,2,3,6-tetrahydro-4-(4-methoxyphenyl)-1-methyl-

Catalog No.:AG000AYR MDL No.:

MF:C13H17NO MW:203.2802

CAS No. 114284-27-4

Pyridine, 1-cyclohexyl-1,2,3,6-tetrahydro-4-phenyl-

Catalog No.:AG000AYQ MDL No.:

MF:C17H23N MW:241.3712

CAS No. 114284-32-1

1H-Triazirin-1-amine, N-[(2-nitrophenyl)methylene]-

Catalog No.:AG000AYP MDL No.:

MF:C7H5N5O2 MW:191.1469

CAS No. 114284-34-3

Phosphoramidic acid, [(propylamino)carbonyl]-, dimethyl ester (9CI)

Catalog No.:AG000AYO MDL No.:

MF:C6H15N2O4P MW:210.1681

CAS No. 114284-41-2

Benzamide, N-[(4,5-dihydro-2-phenyl-5-oxazolyl)methyl]-

Catalog No.:AG000AYN MDL No.:

MF:C17H16N2O2 MW:280.3211

CAS No. 114284-49-0

Benzamide, N-phenyl-N-(1-phenyl-1H-tetrazol-5-yl)-

Catalog No.:AG000AYM MDL No.:

MF:C20H15N5O MW:341.3660

CAS No. 114284-56-9

8-Nonenoic acid, 6-hydroxy-6-(2-propen-1-yl)-, methyl ester

Catalog No.:AG000AYL MDL No.:

MF:C13H22O3 MW:226.3120

CAS No. 114284-69-4

Aluminum, tris(4-ethylphenyl)-

Catalog No.:AG000AYK MDL No.:

MF:C24H27Al MW:342.4527

CAS No. 114284-70-7

1,3-Dioxolo[4,5-g]quinolin-6-amine, N,N-diethyl-7-phenyl-

Catalog No.:AG000AYJ MDL No.:

MF:C20H20N2O2 MW:320.3850

CAS No. 114288-49-2

Morpholine, 4-(1-piperidinylthio)-

Catalog No.:AG000AYI MDL No.:

MF:C9H18N2OS MW:202.3170

CAS No. 114288-53-8

Phenol, 4-[9-(4-hydroxy-3-methylphenyl)-9H-fluoren-9-yl]-2,6-dimethyl-

Catalog No.:AG000AYH MDL No.:

MF:C28H24O2 MW:392.4890

© 2019 Angene International Limited. All rights Reserved.